C276-1709 Screening compound: 7-(9-ethyl-9H-carbazol-3-yl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-5-carboxylic acid

C276-1709 Screening compound: 7-(9-ethyl-9H-carbazol-3-yl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-5-carboxylic acid
C276-1709 Screening compound: 7-(9-ethyl-9H-carbazol-3-yl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-5-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound C276-1709
7-(9-ethyl-9H-carbazol-3-yl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-5-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C276-1709

Molecular Formula

C20H17N5O2 (C20 H17 N5 O2)

Compound Name

7-(9-ethyl-9H-carbazol-3-yl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-5-carboxylic acid

IUPAC name

7-(9-ethyl-9H-carbazol-3-yl)-4H7H-[124]triazolo[15-a]pyrimidine-5-carboxylic acid

SMILES

CCn1c(ccc(C2n3ncnc3NC(C(O)=O)=C2)c2)c2c2c1cccc2

InChI

InChI=1S/C20H17N5O2/c1-2-24-16-6-4-3-5-13(16)14-9-12(7-8-17(14)24)18-10-15(19(26)27)23-20-21-11-22-25(18)20/h3-11,18H,2H2,1H3,(H,26,27)(H,21,22,23)/t18-/m1/s1

InChI Key

WEVNOECJPRVJEB-GOSISDBHSA-N

MDL Number (MFCD)

MFCD11696163

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

359.39

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.499

Distribution Coefficient, logD

-0.140

Water Solubility, LogSw

-3.66

Polar Surface Area

67.980

Acid Dissociation Constant (pKa)

3.76

Base Dissociation Constant (pKb)

-0.74

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

15.00

C276-1709 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

KRAS-Targeted Library (16000 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

RNA-Protein Interaction Inhibitors Library (1986 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Targets:
  • Kinases
  • Kinases
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C276-1709 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C276-1709?
Check Price and Availability of C276-1709, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C276-1709 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C276-1709
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C276-1709
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C276-1709 available by request